Neuraxpharm Arzneimittel competitive analysis

Latest publications and patents of Neuraxpharm Arzneimittel New

Explore the latest publications and patents granted to Neuraxpharm Arzneimittel, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Neuraxpharm Arzneimittel against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 25, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

S1P Receptor Modulators For Treating Multiple SclerosisNOVARTISMar 22, 2023
Compositions And Uses For Treating Multiple SclerosisBIOGEN IDEC MAJul 20, 2022
Method For Treating Primary InsomniaNEURIM PHARMACEUTICALSMar 29, 2022
Methods Of Using Sustained Release Aminopyridine CompositionsACORDA THERAPEUTICSDec 6, 2013

Latest PTAB cases involving Neuraxpharm Arzneimittel

Discover the latest PTAB cases involving Neuraxpharm Arzneimittel, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Neuraxpharm Arzneimittel with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
NEURAXPHARM ARZNEIMITTEL4 - - - Highly Aggressive
ACORDA THERAPEUTICS - 3 - 6Non-Active
BIOGEN IDEC MA - 29 - 1Non-Active
BIOGEN MA - 51 - 7Non-Active